News

American Rheumatology Network announces partnership with Augmedix to scale the use of Augmedix to community rheumatology practices across the nation.

SUMMERVILLE, S.C., Aug. 18, 2022 — American Rheumatology Network, LLC (“ARN”), has announced the appointment of Sarah McClain as its Chief Operating Officer (COO) effective immediately. Michael Cooper, chief executive officer, said Sarah’s focus and drive to move forward with ARN’s industry partnerships is tenacious, and her commitment to be an ‘extension of the practice’ …

ARN Announces Sarah McClain as Chief Operating Officer Read More »

American Rheumatology Network announces partnership with Augmedix to scale the use of Augmedix to community rheumatology practices across the nation.

In June 2020, in accordance with the 21st Century Cures Act of 2016 and the Prescription Drug User Fee Act (PDUFA), the U.S. Food and Drug Administration (FDA) launched Project Patient Voice. This patient-focused drug development initiative facilitates systematic approaches to collecting and using meaningful patient and caregiver input, to better inform medical product development and regulatory decision-making, taking the use of real-world evidence (RWE) to a new level.

The Arthritis Foundation, Trio Health (Trio), and American Rheumatology Network (ARN) announce a collaboration to collectively respond to the patient voice as reported in both the Arthritis Foundation’s Live Yes! INSIGHTS study and Trio-ARN’s clinical insights from more than 370,000 rheumatology patients.

American Rheumatology Network (ARN), in partnership with Trio Health, launched ARN Clinical Research to transform drug development for rheumatology research. This technology-driven solution will unite the power of the ARN network with Trio’s proven data management technologies to develop a real-time integrated platform enabling manufacturers to rapidly achieve their goals.

We are pleased to announce we have appointed Michael Cooper as American Rheumatology Network’s (ARN) new CEO, effective immediately. Michael’s appointment reflects ARN’s current state: enthusiastic and ready to take on the future after another strong year of growth and success. We are excited for Michael to guide our company using his unique experience in …

ARN Announces Michael Cooper as Chief Executive Officer Read More »

To Our Members and Partners, American Rheumatology Network (ARN) and Articularis Healthcare Group Inc., (AHG) stands with the rheumatology community, with the Coalition of State Rheumatology Organizations (CSRO), and with the National Organization of Rheumatology Management (NORM) in firm opposition to the CMS “Most Favored Nation Model.” This model poses an immediate threat to patient …

ARN & AHG Position Statement: “Most Favored Nation Model” Read More »

Each patient is unique. What if their treatment path was too? That possibility is at the core of precision medicine. J. Eugene Huffstutter, MD Precision medicine allows patients to receive treatment based on their personal, genetic makeup. It is commonly associated with oncology, where therapies can address patients’ genetic biomarkers rather than just the location …

Affiliate AHG Physician Publishes “Precision Medicine: Redefining Care for Rheumatoid Arthritis” Read More »

Trio Health, a leading technology provider of real-world data and insights on patients announces the launch of the first-ever Patient Voice database in Rheumatology to acknowledge and incorporate the voice of the patient in access programs, clinical development, and brand team care management programs.